Category : Search result: NSE SME stock


Scripbox CEO on IPO Market Trends & Investment Risks

Scripbox CEO Atul Shinghal explains IPO market drivers, warns against listing gains obsession, and shares smart investment strategies for 2025. Learn how to navigate India's booming IPO landscape.

Mother Nutri Foods IPO Subscribed 1.34 Times

Mother Nutri Foods IPO receives healthy investor response with 1.34x subscription. NII portion leads at 2.54x. Company plans Gujarat expansion with ₹39.59 crore issue.

5 SME IPOs Deliver 300-400% Returns in 2025

Cryogenic Ogs, Tankup Engineers, Anondita Medicare, Fabtech Technologies Cleanrooms, and TechD Cybersecurity have emerged as multibaggers in India's SME sector, delivering 300-400% returns to investors despite valuation concerns.

Gallard Steel IPO Lists at 49% Premium on BSE SME

Gallard Steel shares made spectacular debut, listing at 49% premium over IPO price. The ₹37.50 crore issue was oversubscribed 375 times. Discover what drove this massive investor response.

IPO Slowdown: 3 SME Issues Target ₹100 Crore

Primary market activity slows with no mainboard IPOs next week. Three SME IPOs - SSMD Agrotech, K K Silk Mills, Mother Nutri Foods - aim to raise ₹100 crore. Plus, key listings including Excelsoft Technologies.

Gallard Steel IPO Sees Strong Demand, Subscribed 2.18x

Gallard Steel's ₹37.50 crore SME IPO witnessed overwhelming investor response, subscribed 2.18 times on opening day. Shares could list at 27% premium with ₹40 grey market premium. Bidding continues till November 21.

Azad Engineering Stock Rallies 700% in 5 Years

Azad Engineering shares deliver spectacular 700% returns over 5 years, trading strong in range-bound market. Discover this multibagger stock's remarkable journey and future prospects.

Vectras Enprocon Receives BSE SME Approval

Vectras Enprocon Limited secures in-principle approval from BSE SME platform, marking significant milestone for company's growth and investor accessibility. Read full details.

Mahamaya Lifesciences Tepid BSE SME Debut

Mahamaya Lifesciences shares made a soft debut on BSE SME, listing at a 2% premium. The stock later surged, hitting the 5% upper circuit. Stay updated on this developing market story.

SME IPO Boom, Bust & Regulatory Reset Explained

Explore India's SME IPO journey: post-pandemic retail frenzy, 200x oversubscriptions, 50% listing gains, and Sebi's new profitability rules cooling the market. Understand the future.

Workmates Core2Cloud IPO Lists at 90% Premium

Workmates Core2Cloud Solutions shares debuted at ₹90 premium over IPO price on BSE SME platform. The IT solutions provider's strong listing reflects investor confidence in digital transformation services.

SME IPO Boom Fades: Retail Investors Exit

Retail investors are abandoning SME IPOs as listing gains collapse from 40% to 4% amid market volatility and stricter SEBI regulations. Discover why the lottery ticket appeal has disappeared.

Finbud Financial IPO Lists at 10% Premium

Finbud Financial SME IPO made a solid debut on NSE, listing at a 10% premium. Allottees gained as shares opened at ₹157. Discover the key details and market reaction.

Shining Tools IPO Allotment Status Out

Shining Tools IPO allotment is finalised. Learn how to check your status on BSE SME or via the registrar. Shares list on Nov 14. Invest wisely.

Shreeji Global IPO Debuts at 20% Discount

Shreeji Global FMCG IPO made a disappointing stock market debut, listing at ₹100 per share, a 20% discount to its IPO price of ₹125. Investors see no listing gains.

Mahamaya Lifesciences IPO Opens With Nil GMP

Mahamaya Lifesciences IPO subscription begins. The ₹70.44 crore SME issue sees muted interest with a 2% subscription. Check key details, price band, and financials.

Bharti Airtel, Suzlon, Ola Stocks Plunge in Market Correction

Indian stock markets witnessed significant volatility on November 7th with several major players including Bharti Airtel, Suzlon Energy, and Ola facing substantial losses. Discover which stocks emerged as winners and losers in today's trading session.

Curis Lifesciences IPO: 17x Subscription on Day 1

Curis Lifesciences' NSE SME IPO witnesses massive investor response with 17.36 times subscription on Day 1. Discover GMP trends, price band details, and why this pharma stock is creating buzz.

Amber Enterprises Crashes 14% on Weak Q2 Results

Amber Enterprises shares plummeted 14% to a four-month low after disappointing Q2 earnings. Revenue fell 40%, profits crashed 85% - here's the complete analysis and what investors should do now.

Multibagger Stock Rallies 1750% in 5 Years

Discover how Waaree Renewables Technologies became a multibagger sensation, delivering staggering returns while defying broader market trends. Learn why this renewable energy stock continues to attract investor attention.

Page 1 of 4